Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141731 |
| CAS No | NA |
| Mol.F. | C24H23N7O3 |
| Mol.Wt. | 457.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141732 |
| CAS No | NA |
| Mol.F. | C24H25N7O4 |
| Mol.Wt. | 475.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141733 |
| CAS No | NA |
| Mol.F. | C29H32N6O4 |
| Mol.Wt. | 528.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141734 |
| CAS No | NA |
| Mol.F. | C52H64N10O11S |
| Mol.Wt. | 1037.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141735 |
| CAS No | NA |
| Mol.F. | C26H25ClN4O2 |
| Mol.Wt. | 461.0 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141736 |
| CAS No | NA |
| Mol.F. | C14H19N3O2 |
| Mol.Wt. | 261.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141737 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141738 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141739 |
| CAS No | NA |
| Mol.F. | C25H25F6N3O3 |
| Mol.Wt. | 529.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141740 |
| CAS No | NA |
| Mol.F. | C19H13ClN4O6 |
| Mol.Wt. | 428.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141741 |
| CAS No | NA |
| Mol.F. | C19H14ClN3O5 |
| Mol.Wt. | 399.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141742 |
| CAS No | NA |
| Mol.F. | C19H14ClN3O5 |
| Mol.Wt. | 399.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141743 |
| CAS No | NA |
| Mol.F. | C12H18N6O8S |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141744 |
| CAS No | NA |
| Mol.F. | C27H32N2O4 |
| Mol.Wt. | 448.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141745 |
| CAS No | NA |
| Mol.F. | C13H19N7O5 |
| Mol.Wt. | 353.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141746 |
| CAS No | NA |
| Mol.F. | C27H39N13O9 |
| Mol.Wt. | 689.7 |
| INV STATUS | CUSTOM SYNTHESIS |